share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股sec公告 ·  05/17 17:03
Moomoo AI 已提取核心信息
Applied UV, Inc. has reported a notice of non-compliance with Nasdaq Listing Rule 5605, received on May 15, 2024, due to the resignation of Eugene Burleson from the Board of Directors, leaving the Audit Committee with only two independent directors instead of the required three. The company, headquartered in Mount Vernon, NY, is listed on The Nasdaq Stock Market LLC with common stock under the symbol AUVI and 10.5% Series A Cumulative Perpetual Preferred Stock under AUVIP. Applied UV has been granted a cure period until the earlier of its next annual shareholders' meeting or May 7, 2025, to resolve the issue, with a deadline of November 4, 2024, if the annual meeting occurs before that date. The company plans to elect an additional independent director to the Audit Committee within this timeframe. This event has not affected the trading of Applied UV's common stock on The Nasdaq Capital Market. Additionally, on May 14, 2024, Christopher Kochuba was appointed to the Audit Committee and compensation committee of the Board.
Applied UV, Inc. has reported a notice of non-compliance with Nasdaq Listing Rule 5605, received on May 15, 2024, due to the resignation of Eugene Burleson from the Board of Directors, leaving the Audit Committee with only two independent directors instead of the required three. The company, headquartered in Mount Vernon, NY, is listed on The Nasdaq Stock Market LLC with common stock under the symbol AUVI and 10.5% Series A Cumulative Perpetual Preferred Stock under AUVIP. Applied UV has been granted a cure period until the earlier of its next annual shareholders' meeting or May 7, 2025, to resolve the issue, with a deadline of November 4, 2024, if the annual meeting occurs before that date. The company plans to elect an additional independent director to the Audit Committee within this timeframe. This event has not affected the trading of Applied UV's common stock on The Nasdaq Capital Market. Additionally, on May 14, 2024, Christopher Kochuba was appointed to the Audit Committee and compensation committee of the Board.
Applied UV, Inc. 报告说，由于尤金·伯勒森辞去董事会职务，审计委员会只有两名独立董事，而不是规定的三名，因此于2024年5月15日收到一份关于不遵守纳斯达克上市规则5605的通知。该公司总部位于纽约州弗农山，在纳斯达克股票市场有限责任公司上市，普通股代码为AUVI，A系列累积永久优先股以AUVIP命名，10.5％的A系列累积永久优先股。如果年会在此日期之前举行，Applied UV已获准在下次年度股东大会或2025年5月7日之前解决该问题的治愈期，截止日期为2024年11月4日。公司计划在这段时间内为审计委员会增选一名独立董事。该事件并未影响应用紫外光普通股在纳斯达克资本市场的交易。此外，克里斯托弗·科丘巴于2024年5月14日被任命为董事会审计委员会和薪酬委员会成员。
Applied UV, Inc. 报告说，由于尤金·伯勒森辞去董事会职务，审计委员会只有两名独立董事，而不是规定的三名，因此于2024年5月15日收到一份关于不遵守纳斯达克上市规则5605的通知。该公司总部位于纽约州弗农山，在纳斯达克股票市场有限责任公司上市，普通股代码为AUVI，A系列累积永久优先股以AUVIP命名，10.5％的A系列累积永久优先股。如果年会在此日期之前举行，Applied UV已获准在下次年度股东大会或2025年5月7日之前解决该问题的治愈期，截止日期为2024年11月4日。公司计划在这段时间内为审计委员会增选一名独立董事。该事件并未影响应用紫外光普通股在纳斯达克资本市场的交易。此外，克里斯托弗·科丘巴于2024年5月14日被任命为董事会审计委员会和薪酬委员会成员。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息